{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:23:54Z","timestamp":1776248634399,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11596-020-2266-1","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T18:03:09Z","timestamp":1603994589000},"page":"871-878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AICAR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity"],"prefix":"10.1007","volume":"40","author":[{"given":"Xiao-ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-tao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"6","key":"2266_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nature Rev, Cancer, 2007,7(6):441\u2013453","journal-title":"Nature Rev, Cancer"},{"issue":"5","key":"2266_CR2","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1016\/S2352-3026(15)00048-4","volume":"2","author":"K Sasaki","year":"2015","unstructured":"Sasaki K, Strom SS, O\u2019Brien S, et al. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol, 2015,2(5):e186\u2013e193","journal-title":"Lancet Haematol"},{"issue":"24","key":"2266_CR3","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","volume":"34","author":"H Bower","year":"2016","unstructured":"Bower H, Bjorkholm M, Dickman PW, et al. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. J Clin Oncol, 2016,34(24):2851\u20132857","journal-title":"J Clin Oncol"},{"issue":"1","key":"2266_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","volume":"17","author":"S Soverini","year":"2018","unstructured":"Soverini S, Mancini M, Bavaro L, et al. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy. Mol Cancer, 2018,17(1):49","journal-title":"Mol Cancer"},{"issue":"20","key":"2266_CR5","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","volume":"118","author":"S Chu","year":"2011","unstructured":"Chu S, Mcdonald T, Lin A, et al. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood, 2011,118(20):5565\u20135572","journal-title":"Blood"},{"issue":"12","key":"2266_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood, 2017,129(12):1595\u20131606","journal-title":"Blood"},{"issue":"22","key":"2266_CR7","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/cncr.30864","volume":"123","author":"P Jain","year":"2017","unstructured":"Jain P, Kantarjian HM, Ghorab A, et al. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients. Cancer, 2017,123(22):4391\u20134402","journal-title":"Cancer"},{"issue":"6","key":"2266_CR8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell, 2012,148(6):1145\u20131159","journal-title":"Cell"},{"issue":"4","key":"2266_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc2817","volume":"10","author":"DA Tennant","year":"2010","unstructured":"Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer, 2010,10(4):267\u2013277","journal-title":"Nat Rev Cancer"},{"issue":"3191","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science, 1956,123(3191):309\u2013314","journal-title":"Science"},{"issue":"6","key":"2266_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 2006,9(6):425\u2013434","journal-title":"Cancer Cell"},{"issue":"5930","key":"2266_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"H M Vander","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009,324 (5930):1029\u20131033","journal-title":"Science"},{"issue":"1","key":"2266_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab, 2016,23(1):27\u201347","journal-title":"Cell Metab"},{"issue":"10","key":"2266_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med, 2017,23(10):1234\u20131240","journal-title":"Nat Med"},{"issue":"19","key":"2266_CR15","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","volume":"10","author":"S Gottschalk","year":"2004","unstructured":"Gottschalk S, Anderson N, Hainz C, et al. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res, 2004,10(19):6661\u20136668","journal-title":"Clin Cancer Res"},{"key":"2266_CR16","doi-asserted-by":"crossref","unstructured":"Horibata S, Vo TV, Subramanian V, et al. Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. J Vis Exp, 2015(99):e52727","DOI":"10.3791\/52727"},{"issue":"3","key":"2266_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.pharmthera.2003.09.002","volume":"100","author":"AS Tsiftsoglou","year":"2003","unstructured":"Tsiftsoglou AS, Pappas IS, Vizirianakis IS. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther, 2003,100(3):257\u2013290","journal-title":"Pharmacol Ther"},{"issue":"10","key":"2266_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tcb.2013.05.004","volume":"23","author":"M Agathocleous","year":"2013","unstructured":"Agathocleous M, Harris WA. Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol, 2013,23(10):484\u2013492","journal-title":"Trends Cell Biol"},{"issue":"1","key":"2266_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/imr.12234","volume":"263","author":"TL Holyoake","year":"2015","unstructured":"Holyoake TL, Helgason GV. Do we need more drugs for chronic myeloid leukemia? Immunol Rev, 2015,263(1):106\u2013123","journal-title":"Immunol Rev"},{"issue":"3","key":"2266_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and Cancer. Cell, 2016,166(3):555\u2013566","journal-title":"Cell"},{"issue":"5","key":"2266_CR21","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","volume":"54","author":"I Bogacka","year":"2005","unstructured":"Bogacka I, Xie H, Bray GA, et al. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes, 2005,54(5):1392\u20131399","journal-title":"Diabetes"},{"issue":"6","key":"2266_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1124\/mol.106.033845","volume":"71","author":"S Ghosh","year":"2007","unstructured":"Ghosh S, Patel N, Rahn D, et al. The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Mol Pharmacol, 2007,71(6):1695\u20131702","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2266_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","volume":"55","author":"D Kukidome","year":"2006","unstructured":"Kukidome D, Nishikawa T, Sonoda K, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes, 2006,55(1):120\u2013127","journal-title":"Diabetes"},{"key":"2266_CR24","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1038\/cddis.2013.341","volume":"4","author":"YH Noh","year":"2013","unstructured":"Noh YH, Kim K, Shim MS, et al.. Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes. Cell Death Dis, 2013,4:e820","journal-title":"Cell Death Dis"},{"issue":"2","key":"2266_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","volume":"229","author":"JM Corton","year":"1995","unstructured":"Corton JM, Gillespie JG, Hawley SA, et al. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem, 1995,229(2):558\u2013565","journal-title":"Eur J Biochem"},{"issue":"7241","key":"2266_CR26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 2009,458(7241):1056\u20131060","journal-title":"Nature"},{"issue":"21","key":"2266_CR27","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","volume":"375","author":"JS Welch","year":"2016","unstructured":"Welch JS, Petti AA, Miller CA, et al. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med, 2016,375(21):2023\u20132036","journal-title":"N Engl J Med"},{"issue":"7","key":"2266_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-134-7-200104030-00011","volume":"134","author":"V Santini","year":"2001","unstructured":"Santini V, Kantarjian HM, Issa JP. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med, 2001,134(7):573\u2013586","journal-title":"Ann Intern Med"},{"issue":"3","key":"2266_CR29","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1096\/fj.201801559RR","volume":"33","author":"L Du","year":"2019","unstructured":"Du L, Yang F, Fang H, et al. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells. FASEB J, 2019,33(3):4525\u20134537","journal-title":"FASEB J"},{"issue":"4","key":"2266_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.biopha.2013.01.004","volume":"67","author":"DY Shin","year":"2013","unstructured":"Shin DY, Sung Kang H, Kim G, et al. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2\/M phase through p53-independent pathway in human cancer cells. Biomed Pharmacother, 2013,67(4):305\u2013311","journal-title":"Biomed Pharmacother"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-020-2266-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T08:15:20Z","timestamp":1604045720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-020-2266-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s11596-020-2266-1","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}